These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15324602)

  • 21. Estrogen: effects on normal brain function and neuropsychiatric disorders.
    Craig MC; Murphy DG
    Climacteric; 2007 Oct; 10 Suppl 2():97-104. PubMed ID: 17882683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.
    Henderson VW
    J Steroid Biochem Mol Biol; 2014 Jul; 142():99-106. PubMed ID: 23727128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Action of estrogens in the aging brain: dementia and cognitive aging.
    Henderson VW
    Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?
    Birge SJ
    J Am Geriatr Soc; 1996 Jul; 44(7):865-70. PubMed ID: 8675940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers.
    Miller KJ
    Curr Psychiatry Rep; 2003 Dec; 5(6):439-44. PubMed ID: 14609498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Future therapeutic developments of estrogen use.
    Fillit H
    J Clin Pharmacol; 1995 Sep; 35(9S):25S-28S. PubMed ID: 8530715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.
    Yaffe K; Krueger K; Cummings SR; Blackwell T; Henderson VW; Sarkar S; Ensrud K; Grady D
    Am J Psychiatry; 2005 Apr; 162(4):683-90. PubMed ID: 15800139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?
    Mills ZB; Faull RLM; Kwakowsky A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease.
    Green PS; Simpkins JW
    Ann N Y Acad Sci; 2000; 924():93-8. PubMed ID: 11193809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease.
    Greene RA
    Int J Fertil Womens Med; 2000; 45(4):253-7. PubMed ID: 10997480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy and Alzheimer's disease.
    van Duijn CM
    Maturitas; 1999 Mar; 31(3):201-5. PubMed ID: 10340279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidants for the treatment of mild cognitive impairment.
    Mecocci P; Mariani E; Cornacchiola V; Polidori MC
    Neurol Res; 2004 Jul; 26(5):598-602. PubMed ID: 15265281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.
    Hogervorst E; Williams J; Budge M; Riedel W; Jolles J
    Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.
    Simpkins JW; Singh M; Bishop J
    Neurobiol Aging; 1994; 15 Suppl 2():S195-7. PubMed ID: 7700453
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women.
    Fillenbaum GG; Hanlon JT; Landerman LR; Schmader KE
    Am J Epidemiol; 2001 Jan; 153(2):137-44. PubMed ID: 11159158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing Alzheimer disease and cognitive decline.
    Naftolin F; Harman SM
    Ann Intern Med; 2011 Feb; 154(3):211-2; author reply 212-3. PubMed ID: 21282704
    [No Abstract]   [Full Text] [Related]  

  • 38. Alzheimer's disease: an estrogen link?
    Beckmann CR
    Curr Opin Obstet Gynecol; 1997 Oct; 9(5):295-9. PubMed ID: 9360809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical menopause and cognitive decline.
    Pines A
    Climacteric; 2014 Oct; 17(5):580-2. PubMed ID: 24502814
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.